The practice of covertly administering medications to patients without their consent is often discussed in the framework of legal questions around the right of patients to consent and refuse medical treatment. However, this practice also raises significant questions surrounding the professional duties and obligations of health care professionals as it relates to the decision-making process of whether to engage in the covert administration of medications. In this paper, I present an overview of the origin of those duties and obligations, and discuss how those duties and obligations when seen from different perspectives may either justify or prohibit the practice. Further, I discuss whether the duties and obligations of health care professionals as they are currently framed are suited to address the complexities of this issue both from the health care professional and patient perspectives. This analysis is conducted in the context of duties and obligations that arise from not only legal framework but also from the ethical requirements from professional codes of ethics.
Get full access to this article
View all access options for this article.
References
1.
A.Treloar, M.Philpot, and B.Beats, “Concealing Medication in Patients' Food,”The Lancet: Viewpoint357 (January6, 2001): 62, at 62.
C.Haw and J.Stubbs, “Administration of Medicines in Food and Drink: A Study of Older Inpatients with Severe Mental Illness,”International Psychogeriatrics22, no. 3 (2010): 409-416; C. Haw and J. Stubbs, “Covert Administration of Medications to Older Adults: A Review of the Literature and Published Studies,” Journal of Psychiatric and Mental Health Nursing 17 (2010): 761-768.
A.Treloar, B.Beats, and M.Philpot, “A Pill in the Sandwich: Covert Medication in Food and Drink,”Journal of the Royal Society of Medicine93, no. 8 (2000): 408-11.
8.
R.Elvish, I.James, and D.Milne, “Lying in Dementia Care: An Example of a Culture That Deceives in People's Best Interest,”Aging & Mental Health14, no. 3 (April2010): 255-262.
9.
Elvish, James and Milne, supra note 8.
10.
C.Haw and J.Stubbs, “Covert Administration of Medications to Older Adults: A Review of the Literature and Published Articles,”Journal of Psychiatric and Mental Health Nursing17, no 9 (2010): 761.
11.
See Haw and Stubbs, supra note 10.
12.
Id.
13.
Id. See also, Treloar, Philpot, and Beats, supra note 1, where the authors argue that the practice of covert medications is often carried out in secrecy which result is health care staff failing to discuss the issue with others, which can give rise to patient abuse.
O.Kirkevold and K.Engedal, “Concealment of Drugs in Food and Beverages in Nursing Homes: Cross Sectional Study,”British Medical Journal330, no. 20 (2004). 1-4
19.
See for example, Health Care Consent Act, 1996, S.O. 1996, c.2, Sch.A., s. 4(1); Hospitals Act, R.S.N.S. 1989, c. 208.
20.
Ciarlariello v. Schacter, [1993] 2 S.C.R. 119 at para. 135.
21.
R. v. Big M Drug Mart Ltd., [1985] 1 S.C.R. 295 at 346.
22.
Fleming v. Reid (1991), 4 O.R. (3d) 74 (C.A.).
23.
Charter of Rights and Freedoms, Part I of the Constitution Act, 1982, being Schedule B to the Canada Act 1982 (U.K.), 1982, c. 11.
24.
Fleming v. Reid (1991), 4 O.R. (3d) 74 (C.A.).
25.
Ciarlariello v. Schacter, [1993] 2 S.C.R. 119.
26.
Supra note 25, at 133.
27.
Rodriguez v. British Columbia (Attorney General), [1993] 3 S.C.R. 519.
28.
Supra note 27, at 618.
29.
Starson v. Swayze, [2003] 1 S.C.R. 722, 2003 SCC 32.
30.
Carter v. Canada (Attorney General) 2015 SCC 5, [2015] 1 S.C.R. 331.
31.
Supra note 30, at para. 67.
32.
See for example, Health Care Consent Act, 1996, S.O. 1996, c. 2, Sched. A; Hospitals Act, R.S.N.S 1989, c. 208; Health Care (Consent) and Care Facility (Admission) Act, RSBC 1996, c 181.
33.
Health and Disability Commissioner (Code of Health and Disability Services Consumers' Rights) Regulations 1996, the Right number 7 of the Code is the right to make an informed choice and give informed consent.
34.
Patient's Rights Act, 1996. Section 13A requires that no medical care shall be given unless and until the patient has given his informed consent to it.
35.
S.Zimring, “Health Care Decision-Making Capacity: A Legal Perspective for Long-Term Care Providers”Journal of the American Medical Directors Association7, no 5 (June2006): 322-326.
36.
Hawaii Revised Statutes, Div. 1, Title 19, Ch.327-E7.
37.
Oregon Revised Statutes, Title 13, Ch. 677.507.
38.
Texas Health and Safety Code, Title 2, Subtitle H, Ch. 166, ss.166.045-166.046.
39.
Aintree University Hospitals NHS Foundation Trust v. James, [2013] UKSC 67.
40.
Supra note 39 at paras. 19 to 23.
41.
Hospitals Act, RSNS 1989 c. 208, section 54(2).
42.
Northamptonshire Healthcare (“NHS Foundation Trust”), supra note 17.
43.
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. NICE is an executive non-departmental public body, sponsored by the UK Department of Health.
The Royal College of Psychiatrists, “College Statement on Covert Administration of Medications.”The Psychiatrist, available at <http://www.rcpsych.ac.uk/pdf/covertmedicine.full.pdf> (last visited May 3, 2017).
48.
The Royal College of Psychiatrists, supra note 47.
O. Eckman, Telling Lies: Clues to Deceit in the Marketplace, Politics and Marriage (New York: Norton, 1985).
67.
R.Elvish, I.James, and D.Milne, “Lying in Dementia care: An Example of a Culture that Deceives in People's Best Interest,”Aging & Mental Health14, no. 3 (April2010): 255-262, at 255.
68.
Elvish, James, and Milne, supra note 8, at 255.
69.
K.Erick, D.Hung, E.McNeil, and R. L.Binder, “Covert Medication in Psychiatric Emergencies: Is It Ever Ethically Permissable?”Journal of the American Academy of Psychiatry and the Law40 (2012): 239-245, at 243. See also T. N. Srinivasan and R. Thara, “At Issue: Management of Medication Noncompliance in Schizophrenia by Families in India,” Schizophrenia Bull 28 (2002): 531-535. Srinivasan and Thara found that patients that subsequently found out that they had been given mediations covertly by their family member had anger and resentment toward the family members who gave the medications covertly.
70.
K.Teasdale and G.Kent, “The Use of Deception in Nursing,”Journal of Medical Ethics21, no. 2 (1995): 77-81.
71.
D.Olsen, “Ethical Issues: Putting the Meds in the Apple-sauce,”American Journal of Nursing112, no. 3 (March2012) 67-69.
72.
Id.
73.
Canadian Nurses Association, supra note 49.
74.
College of Registered Nurses of Manitoba, Interpretative Document: Covert Medications Administration, at 1, available at <https://www.crnm.mb.ca/support/resources> (last visited May 3, 2017).
75.
College Registered Nurses Nova Scotia, 2015, supra note 54.
76.
College of Registered Nurses of Manitoba, supra note 74, at 1.
77.
College of Registered Nurses of Manitoba, supra note 74.
78.
College of Registered Nurses of Manitoba, supra note 74, at 2.
79.
Treloar et al., supra note 1.
80.
S.Bok, Lying: Moral Choice in Public and Private Life (New York: Vintage Books, 1978).
81.
D. P.Olsen, “Ethical Issues: Putting the Meds in the Apple-sauce,”American Journal of Nursing112, no. 3 (2012): 67-69.
